{"id":6803,"date":"2022-03-05T12:00:00","date_gmt":"2022-03-05T12:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3680428_AE80428_0"},"modified":"2022-03-05T12:00:00","modified_gmt":"2022-03-05T12:00:00","slug":"new-robotic-assisted-transperineal-needle-guidance-system-for-prostate-biopsy-and-cancer-ablations-received-u-s-fda-510k-clearance","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=6803","title":{"rendered":"New Robotic Assisted Transperineal Needle-Guidance System for Prostate Biopsy and Cancer Ablations Received U.S FDA 510(k) Clearance"},"content":{"rendered":"
<\/div>\n

SINGAPORE<\/span>, March 5, 2022<\/span> \/PRNewswire\/ — Biobot Surgical is excited to announce U.S. FDA 510(k) clearance of the iSR’obot Mona Lisa 2.0. The new robotic assisted transperineal needle-guidance system allows urologists to plan and position a single needle or multiple needles during image-guided diagnostic and interventional prostate procedures.<\/p>\n

The iSR’obot Mona Lisa 2.0 is the latest addition to Biobot Surgical’s iSR’obot Mona Lisa product portfolio. “The Mona Lisa system was conceptualized and engineered to position biopsy or treatment needles transperineally. The advantages of transperineal procedures are lower infection rates and better coverage of the anterior zone compared to transrectal procedures. In addition, most ablation procedures are also carried out transperineally. The Mona Lisa system simplifies needle positioning by providing robotic assisted guidance for the insertion.” said Sim Kok Hwee<\/span>, CEO of Biobot Surgical.<\/p>\n

The iSR’obot Mona Lisa 2.0 automatically supports needle positioning during transperineal prostate biopsy and prostate cancer ablation based on a customized needle plan. <\/p>\n

The new features include:  <\/p>\n